413 LONG-TERM DEFERASIROX THERAPY IS ASSOCIATED WITH STABILIZATION OR IMPROVEMENT OF LIVER FIBROSIS AND NECROINFLAMMATION IN PATIENTS WITH ß-THALASSEMIA REGARDLESS OF HEPATITIS C STATUS